secwatch.observer — SEC 8-K summary
======================================

Issuer:     INVO Fertility, Inc. (IVF)
CIK:        0001417926
Form:       8-K/A
Filed at:   2024-01-10T23:59:59+00:00
Accession:  0001493152-24-001962
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INVO Bioscience amends merger terms, extends deadline to April 30, 2024; corrects NAYA share count to 1M
--------------------------------------------------------------------------------

- Second Amendment extends merger end date to April 30, 2024; interim private offering minimum reduced to $2M from $5M.
- NAYA purchases 1M shares of Series A Preferred at $5/share per schedule; $500K due Dec 29 not yet received as of Jan 3.
- Convertible Notes ($410K) maturity extended to June 30, 2024; conversion/exercise prices lowered to $2.25 from $10/$12.
- CEO Steve Shum and CFO Andrea Goren salaries reverted to $260K and $215K on Jan 1, 2024 after temporary cut to $105K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417926/000149315224001962/0001493152-24-001962-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417926/000149315224001962/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-001962

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer